Pharmaron is a leading neurology CRO offering comprehensive in vitro neurology assay services engineered to tackle complex neuroscience challenges, including Alzheimer’s, Parkinson’s, neuroinflammation, neurodegenerative diseases, and other related conditions. Our in vitro disease model solutions combine leading-edge technologies with skilled scientists to deliver actionable insights.

Key benefits of Pharmaron’s in vitro Neurology Assays:

1. Broad Research Scope: We cover an expansive range of targets, including neurotransmitter receptors and transporters, GPCRs, neuroinflammation targets, and targets related to neurodegeneration and cellular stress.
2. Advanced Neurology Assay Technologies: Our neurology assays range from basic binding tests on cell cultures to complex tissue-based readouts on brain slices, as well as high-content imaging, MEA recordings, and automated high-throughput patch techniques.
3. Fast Turnaround Times: Our in vitro neurology assays are designed to achieve turnaround times of 3-5 days for radioligand assays and 10-15 days for primary cell-based studies.
4. Expert-Driven Solutions: Our neurology team’s 40+ scientists enable direct communication, allowing us to tailor the assay and screening protocol to your specific research needs. We constantly create new disease models to ensure that our clients stay ahead.

Download our service overview to explore our comprehensive neurology CRO services.